Risk Management Only Part Of Behind-The-Counter Orders – Von Eschenbach
This article was originally published in The Tan Sheet
Executive Summary
Enactment of legislation to strengthen FDA's post-marketing authority is not the only hurdle to clear before the agency could begin requiring behind-the-counter sales of certain nonprescription drugs, Commissioner Andrew von Eschenbach says